Detalles de la búsqueda
1.
Design, Synthesis, and Characterization of an Orally Active Dual-Specific ULK1/2 Autophagy Inhibitor that Synergizes with the PARP Inhibitor Olaparib for the Treatment of Triple-Negative Breast Cancer.
J Med Chem
; 63(23): 14609-14625, 2020 12 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33200929
Resultados
1 -
1
de 1
1
Próxima >
>>